Drug intelligence / Profile preview

spirulina fusiformis

Development stage
Unknown
Lead developer
DIC Corporation
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Spirulina fusiformis is a species of blue-green microalgae (cyanobacteria) that serves as a dense natural source of proteins, carotenoids, and essential micronutrients. It has been clinically investigated for its chemopreventive properties, particularly in the treatment of oral leukoplakia among tobacco chewers. In a landmark study conducted in Kerala, India, daily supplementation with 1 gram of Spirulina fusiformis for twelve months resulted in a significant complete regression of oral lesions compared to placebo, particularly in homogeneous leukoplakia. While it is an effective dietary source of vitamin A precursors, its therapeutic effects in oncology are thought to derive from its complex antioxidant profile rather than a simple increase in serum retinol levels. It is widely available as a nutraceutical and dietary supplement.

Other names
SpirulinaSFblue-green microalgae

Beyond the preview

Go deeper on spirulina fusiformis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on spirulina fusiformis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call